GLOBAL BIO-CHEM (00809) Completes Issuance of Consideration Shares Under Special Mandate and Conversion of Convertible Bonds

Stock News

Oct 02

GLOBAL BIO-CHEM (00809) announced that the board of directors is pleased to announce that all precedent conditions under Share Purchase Agreement I and Share Purchase Agreement II have been fulfilled, and pursuant to the terms and conditions of each share purchase agreement, the share purchase agreements were completed on October 2, 2025. A total of 2.753 billion consideration shares have been issued. The company received conversion notices from bondholders regarding the full exercise of their conversion rights under the convertible bonds, converting convertible bonds with a principal amount of HK$1.086 billion into 5.173 billion conversion shares at a conversion price of HK$0.21 per conversion share. Accordingly, following completion of the necessary administrative procedures for the allotment of conversion shares, the company allotted and issued 5.173 billion conversion shares to the bondholders on October 2, 2025, which rank pari passu in all respects among themselves and with all other existing shares in issue (conversion).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1179387624"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1179387624\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1179387624?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-02 19:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1179387624","market":"hk","top_or_hot":-1,"title":"GLOBAL BIO-CHEM (00809) Completes Issuance of Consideration Shares Under Special Mandate and Conversion of Convertible Bonds","media":"Stock News","content":"<p>GLOBAL BIO-CHEM (00809) announced that the board of directors is pleased to announce that all precedent conditions under Share Purchase Agreement I and Share Purchase Agreement II have been fulfilled, and pursuant to the terms and conditions of each share purchase agreement, the share purchase agreements were completed on October 2, 2025. A total of 2.753 billion consideration shares have been issued. The company received conversion notices from bondholders regarding the full exercise of their conversion rights under the convertible bonds, converting convertible bonds with a principal amount of HK$1.086 billion into 5.173 billion conversion shares at a conversion price of HK$0.21 per conversion share. Accordingly, following completion of the necessary administrative procedures for the allotment of conversion shares, the company allotted and issued 5.173 billion conversion shares to the bondholders on October 2, 2025, which rank pari passu in all respects among themselves and with all other existing shares in issue (conversion).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GLOBAL BIO-CHEM (00809) Completes Issuance of Consideration Shares Under Special Mandate and Conversion of Convertible Bonds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGLOBAL BIO-CHEM (00809) Completes Issuance of Consideration Shares Under Special Mandate and Conversion of Convertible Bonds\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-10-02 19:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GLOBAL BIO-CHEM (00809) announced that the board of directors is pleased to announce that all precedent conditions under Share Purchase Agreement I and Share Purchase Agreement II have been fulfilled, and pursuant to the terms and conditions of each share purchase agreement, the share purchase agreements were completed on October 2, 2025. A total of 2.753 billion consideration shares have been issued. The company received conversion notices from bondholders regarding the full exercise of their conversion rights under the convertible bonds, converting convertible bonds with a principal amount of HK$1.086 billion into 5.173 billion conversion shares at a conversion price of HK$0.21 per conversion share. Accordingly, following completion of the necessary administrative procedures for the allotment of conversion shares, the company allotted and issued 5.173 billion conversion shares to the bondholders on October 2, 2025, which rank pari passu in all respects among themselves and with all other existing shares in issue (conversion).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1212","symbol_name":"农产品","start_time":0,"source_url":"","article_id":"1179387624","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179387624","pubTimestamp":1759404494,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"GLOBAL BIO-CHEM (00809) announced that the board of directors is pleased to announce that all precedent conditions under Share Purchase Agreement I and Share Purchase Agreement II have been...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1212":"农产品","00809":"大成生化科技"},"translate_title":"环球生化(00809)完成根据特别授权发行代价股份及转换可换股债券","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00809":1},"content_text":"GLOBAL BIO-CHEM (00809) announced that the board of directors is pleased to announce that all precedent conditions under Share Purchase Agreement I and Share Purchase Agreement II have been fulfilled, and pursuant to the terms and conditions of each share purchase agreement, the share purchase agreements were completed on October 2, 2025. A total of 2.753 billion consideration shares have been issued. The company received conversion notices from bondholders regarding the full exercise of their conversion rights under the convertible bonds, converting convertible bonds with a principal amount of HK$1.086 billion into 5.173 billion conversion shares at a conversion price of HK$0.21 per conversion share. Accordingly, following completion of the necessary administrative procedures for the allotment of conversion shares, the company allotted and issued 5.173 billion conversion shares to the bondholders on October 2, 2025, which rank pari passu in all respects among themselves and with all other existing shares in issue (conversion).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}